Completed OBSERVATIONAL NCT03723005

A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns

Sponsor: NeoLight, LLC.

Interventions Neolight Phototherapy Mattress Standard-of-Care

Updated 9 times since 2018 Last updated: Apr 6, 2023 Started: May 1, 2018 Primary completion: Apr 4, 2023 Completion: Apr 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03723005, this observational or N/A phase trial focuses on Hyperbilirubinemia, Neonatal and remains completed. Sponsored by NeoLight, LLC., it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Sep 2022 — May 2023 [monthly]

Recruiting
Oct 2021 — Sep 2022 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting
Feb 2020 — Jan 2021 [monthly]

Recruiting
Nov 2019 — Feb 2020 [monthly]

Recruiting
Nov 2018 — Nov 2019 [monthly]

Recruiting

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeoLight, LLC.
Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palo Alto, United States